This product is regulated by law in Japan and will not be shipped to Japan.
DICLAZEPAM
Drug/Pharma metabolites – Benzodiazepines
Diclazepam (CAS 2894-68-0), otherwise known as chlorodiazepam, is the 2’-chloro analogue of diazepam.
It has similar effects, although reportedly 10 times the potency of diazepam.
It was first synthesised by Hoffman-La Roche in the 1960’s, but is considered a ‘novel’ uncontrolled benzodiazepine by those working in the new psychoactive substance (NPS) field.
The EMCDDA were first notified of Diclazepam in September 2013. Since it is currently uncontrolled in most jurisdictions, diclazepam is being marketed as a legal alternative to etizolam.
The metabolism of diclazepam has not yet been established, but delorazepam is believed to be the active metabolite through N-demethylation.
Recommended amount to use
In general, for adults, 5-15 mg of diclazebum is injected intramuscularly or intravenously as slowly as possible. After that, inject every 3 to 4 hours as needed.
